Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks?

Rahway, New Jersey-based Merck & Co., Inc. (MRK) operates as a healthcare company worldwide. Valued at $256.4 billion by market cap, the company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. 

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and MRK definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the general drug manufacturers industry. Merck is a leader in research and development, with a strong focus on discovering and developing new drugs and vaccines. Through collaborations with academic institutions, biotech firms, and other pharmaceutical companies, Merck maintains a robust pipeline in multiple therapeutic areas. With products like Keytruda and Gardasil, Merck has established itself as a global leader. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.